title: FDA rulemaking after the 104th Congress: major rules enter the twilight zone of review.
authors.affiliation: The Proctor & Gamble Company, USA.
authors.forename: J T
authors.initials: JT
authors.lastname: O'Reilly
mesh_terms: D018166:Health Care Reform; D006801:Humans; D011050:Policy Making; D011057:Politics; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration*